| BGF SWISS SMALL & MIDCAP OPPORTUNITIES I2 CHF | RVI EUROPA SMALL/MID CAP | 10,61% | 7,25% | 12,07% | 148,65% |
| GOLDMAN SACHS US EQUITY ESG PORTFOLIO A USD DIS | RVI USA | 11,36% | 29,47% | 35,14% | 148,64% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY N CAP USD | BIOTECNOLOGÍA | 48,16% | 49,27% | 58,47% | 148,59% |
| M&G (LUX) ASIAN FUND EUR A ACC | RVI ASIA EX-JAPÓN | 40,80% | 57,51% | 56,64% | 148,52% |
| UBS (LUX) EQUITY SICAV - US TOTAL YIELD (USD) P-ACC | RVI USA VALOR | 22,69% | 35,43% | 51,61% | 148,45% |
| NEUBERGER BERMAN US MULTI CAP OPPORTUNITIES USD E ACC | RVI USA | 15,40% | 34,55% | 38,02% | 148,43% |
| CHALLENGE NORTH AMERICAN EQUITY L-A | RVI USA | 12,03% | 45,23% | 51,65% | 148,42% |
| SCHRODER ISF EMERGING ASIA A1 ACC EUR | RVI ASIA | 26,73% | 28,98% | 8,88% | 148,36% |
| TEMPLETON EMERGING MARKETS A (ACC) HKD | RVI EMERGENTES | 48,67% | 64,38% | 27,68% | 148,34% |
| NEUBERGER BERMAN US MULTI CAP OPPORTUNITIES USD B ACC | RVI USA | 15,41% | 34,46% | 37,99% | 148,33% |
